E
Euglena
Microalgae-based food, cosmetics, and biofuel development
At a glance
- Status
- Listed
- Founded
- 2005
- Headquarters
- Tokyo, Japan
- Listing
- IPO 2012
- Sector
- Biotech & Life Sciences
- Power Law
- Thoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
- SISBI Investment
Inspire
Series B and later2 investors entered at this stage
- J-J-Startup
- TTThe University of Tokyo
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
74 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Euglena was the backer or acquirer, 2016–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Euglena's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where Euglena deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
Euglena's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Euglena on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Euglena on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.